Genetic Heterogeneity of MET-Aberrant NSCLC and Its Impact on the Outcome of Immunotherapy.
J Thorac Oncol
; 16(4): 572-582, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33309988
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Thorac Oncol
Year:
2021
Type:
Article
Affiliation country:
Germany